Endothelial cells organize fibrin clots into structures that are more resistant to lysis

被引:16
作者
Jerome, WG
Handt, S
Hantgan, RR
机构
[1] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Rhein Westfal TH Aachen, Inst Pathol, D-52072 Aachen, Germany
[4] Wake Forest Univ, Hlth Sci Ctr, Dept Biochem, Winston Salem, NC 27157 USA
关键词
thrombosis; fibrinolysis; fibrin; endothelial cells; integrins; confocal microscopy;
D O I
10.1017/S143192760505052X
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Acute myocardial infarction is a major cause of death and disability in the United States. Introducing thrombolytic agents into the clot to dissolve occlusive coronary artery thrombi is one method of treatment. However, despite advances in our knowledge of thrombosis and thrombolysis, survival rates following thrombolytic therapy have not improved substantially. This failure highlights the need for further study of the factors mediating clot stabilization. Using laser scanning confocal microscopy of clots formed from fluorescein-labeled fibrinogen, we investigated what effect binding of fibrin to the endothelial surface has on clot structure and resistance to lysis. Fluorescent fibrin clots were produced over human umbilical vein endothelial cells (HUVEC) and the clot structure analyzed. In the presence of HUVEC, fibrin near the endothelial surface was more organized and occurred in tighter bundles compared to fibrin just 50 mu m above. The HUVEC influence on fibrin architecture was blocked by inhibitory concentrations of antibodies to alpha(V) or 163 integrin subunits. The regions of the clots associated with endothelial cells were more resistant to lysis than the more homogenous regions distal to endothelium. Thus, our data show that binding of fibrin to integrins on endothelial surfaces produces clots that are more resistant to lysis.
引用
收藏
页码:268 / 277
页数:10
相关论文
共 34 条
[1]  
ANDERSON HV, 1993, NEW ENGL J MED, V329, P703
[2]   Interventional management of acute myocardial infarction (AMI) [J].
Bett, JHN .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (04) :504-509
[3]   PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS [J].
BOOTH, NA ;
SIMPSON, AJ ;
CROLL, A ;
BENNETT, B ;
MACGREGOR, IR .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) :327-333
[4]  
BRAATEN JV, 1994, BLOOD, V83, P982
[5]  
CHANG MC, 1995, THROMB HAEMOSTASIS, V74, P764
[6]   RECOGNITION OF DISTINCT ADHESIVE SITES ON FIBRINOGEN BY RELATED INTEGRINS ON PLATELETS AND ENDOTHELIAL-CELLS [J].
CHERESH, DA ;
BERLINER, SA ;
VICENTE, V ;
RUGGERI, ZM .
CELL, 1989, 58 (05) :945-953
[7]   The evolution of thrombolytic therapy and adjunctive Antithrombotic regimens in acute ST-segment elevation myocardial infarction [J].
Cohen, M ;
Arjomand, H ;
Pollack, CV .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2004, 22 (01) :14-23
[8]  
COLLEN D, 1995, THROMB HAEMOSTASIS, V74, P167
[9]   Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots [J].
Collet, JP ;
Lesty, C ;
Montalescot, G ;
Weisel, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) :21331-21335
[10]  
CONFORTI G, 1992, BLOOD, V80, P437